EN
HI
Kilitch Drugs (India) Share price
KILITCH
181.66
9.56 (-5.00%)NSE
BSE
Last updated on 14 Aug, 2026 | 15:28 IST
Kilitch Drugs (India) share price chart
Kilitch Drugs (India) Share Key Metrics
Volume
7225.00
Market Cap
668.54 CR
LTQ@LTP
2@181.66
ATP
181.66
Var Margin
100 %
Circuit Range
181.66-200.78
Delivery %
0 %
Value
13.12 L
ASM/GSM
No
Market Lot
1
Summary
KILITCH stock price is ₹181.66 as of 14 Aug, 2026. The stock intraday movement has stayed between ₹181.66 and ₹181.66, while Kilitch Drugs (India) share price 52 week high low is ₹117.25 & ₹224.73.
In terms of trading activity, KILITCH share price has recorded a volume of 7,225 shares. The Kilitch Drugs (India) has a market cap of ₹34961564. The stock’s Average Traded Price (ATP) stands at ₹181.66, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹181.66.
The Kilitch Drugs (India) upper circuit limit is ₹200.78 & The Kilitch Drugs (India) lower circuit limit is ₹181.66, with a Value of ₹13.12 L. The Delivery Percentage for the day is 0%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Kilitch Drugs (India) Resistance and Support
Pivot 189.64
Resistance
First Resistance
193.28
Second Resistance
195.34
Third Resistance
198.98
Support
First Support
187.58
Second Support
183.94
Third Support
181.88
Kilitch Drugs (India) Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
63.77%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0.12%
Domestic Institutional Investors
0%
Retail
36.11%
Others
0%
Total Promoters
MAR '26
63.77%
JUN '26
63.77%
Kilitch Drugs (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-07-02 | Others |
| Rights Date | Ratio | |
|---|---|---|
| 2025-07-15 | 2:23 | View More |
Kilitch Drugs (India) News
Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Financial Results For The Quarter Ended 30Th June 2026
Kilitch Drugs board approved Q1 FY27 results on August 13, 2026. Consolidated revenue increased by 4.57% YoY to ₹47.78 cr, though net profit declined by 12.92% YoY to ₹1.97 cr. Standalone net profit for the quarter rose by 5.43% YoY to ₹5.05 cr.
Aug 13 2026 21:04:12
Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2026
Kilitch Drugs (India) Ltd board meeting is scheduled for August 13, 2026. The agenda includes considering and approving the unaudited financial results for the quarter ended June 30, 2026.
Aug 10 2026 10:31:53
Kilitch Drugs (India) Management
| Name | Position |
|---|---|
| Pushpa Nyoupane | Company Secretary & Compliance Officer |
| Mukund P Mehta | Managing Director |
Kilitch Drugs (India) Similar Stocks
Hexagon Nutrition Ltd.
63.98
-0.46 (0.71%)
Anlon Healthcare Ltd.
14.43
0.18 (1.26%)
Influx Healthtech Ltd.
286.35
-9.25 (3.13%)
Osel Devices Ltd.
394.10
10.80 (2.82%)
Bafna Pharmaceuticals Ltd.
257.70
-5.25 (2.00%)
Chandan Healthcare Ltd.
248.00
6.60 (2.73%)
Zim Laboratories Ltd.
107.55
-2.19 (2.00%)
Accent Microcell Ltd.
583.00
13.65 (2.40%)
Kilitch Drugs (India) FAQs
The Buying Price of Kilitch Drugs (India) share is 181.66 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 21.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 2.35. Useful to assess the stock's value relative to its book value.
To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 64.91 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kilitch Drugs (India) is 668.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kilitch Drugs (India) share price is 224.73 & 117.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kilitch Drugs (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in KILITCH
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC